Newsroom

Articles

Mini-Lab presentation at ECCMID 2022 in Lisbon

MSF and the Mini-Lab team were present at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which took place in Lisbon, Portugal from 23 to 26 April 2022.

Read more
Articles

The Mini-Lab is deployed in Aweil, South Sudan in April 2022

The Mini-Lab has been deployed in Aweil, South Sudan in April 2022.

Read more
Articles

Launch of the internal deployment plan

Mini-Lab is now ready to be deployed within the MSF Movement.

Read more
Articles

Mini-Lab collaborates with WHONET

MSF is pleased to announce the partnership between MSF and WHONET to integrate WHONET's expertise into the Laboratory Information Management System (Mini-LIMS) to facilitate the interpretation of antibiotic susceptibility tests (AST)

Read more
Articles

Deployment of the second Mini-LAB pilot on the field in Bangui (Central African Republic)

Read more

Headline

A day at Blantyre cervical cancer referral hospital
Articles

Rehabilitation after cervical cancer treatment in Malawi: how can access for patients be improved?

In Malawi, many women treated for cervical cancer travel long distances to access rehabilitation care, even though it is essential for their recovery. In Blantyre, as part of MSF’s cervical cancer prevention and treatment programme, the MSF Foundation has been developing and supporting a specialised rehabilitation service for women for the past two years. Today, it is working to decentralise this care to make it more accessible. 

Cervical cancer remains a major public health issue in Malawi. The country has one of the highest prevalence rates in the world: nearly 40% of cancers diagnosed in women are cervical cancer, and the disease causes around 3,000 deaths every year. 

Read more

MSF Foundation in Video

News

Publications

  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more

Press Review

No news for now.